Yellow Fever: The Recurring Plague

REFERENCES

• Strode G K. Yellow Fever. McGraw-Hill Book Company Inc., New York 1951
   Google Scholar
• Robertson S E, Hull B P, Tomori O, et al, Yellow Fever: A decade of re-emergence. JAMA. 1996; 276: 1157–62. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• UNICEF/WHO Joint Technical Group on Immunization for the African Region—Report of the Third Meeting. New York, UNICEF. 1988
   Google Scholar
• Tomori O, Nasidi A, Mung K. Status of yellow fever vaccination in the Expanded Programme on Immunization (EPI), Parent du Chatelet I, Schlumberger M, da, Silva A. Proceedings of the 4th International Seminar on Immunization in Africa, Yamoussoukro, Cote d'Ivoire. pp. 107–12, Lyon, Foundation Marcel Merieux. 1994
   Google Scholar
• Zanotto P M, Gould E A, Gao G F, et al, Population dynamics of flaviviruses revealed by molecular phylogenies. Proc Natl Acad Sci USA. 1996; 93: 548–53. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Augustin G. History of Yellow Fever. Searcy and Pfaff Ltd., New Orleans 1909
   Google Scholar
• Kelly H A. Walter Reed and Yellow Fever. McClune, Phillips & Co., New York 1907
   Google Scholar
• Findlay C J. Yellow Fever: Its transmission by means of the Culex mosquito. Am J Med Sci. 1886; 92: 395
   Google Scholar
• Soper F L. Jungle Yellow Fever: New epidemiological entity in South America. Rev Hyg Saude Publica. 1936; 10: 107–44
   Google Scholar
• Shannon R C, Whitman L, Franca M. Yellow fever virus in jungle mosquitoes. Science. 1938; 88: 110–11
   PubMedGoogle Scholar
• Haddow A J, Smithburn K C, Dick G WA, et al, Implication of the mosquito Aedes (Stegomyia) africanus Theobald in forest cycle of yellow fever in Uganda. Ann Trop Med. 1948; 42: 218–23
   PubMed Web of Science ®Google Scholar
• Germain M, Cornet M, Mouchet J, et al, Recent advances in research regarding sylvatic yellow fever in west and central Africa. Bull Inst Pasteur. 1982; 80: 315–30
   Google Scholar
• Theiler M, Smith H H. Use of yellow fever modified by an in vitro cultivation for human immunization. J Exp Med. 1937; 29: 62–4
   Google Scholar
• Theiler M. The development of vaccines against yellow fever—Les Prix Nobel de 1951. Collected papers by members of the staff of the Division of Medicine and Public Health of the Rockefeller Foundation. New York, Rockefeller Foundation. 1952
   Google Scholar
• Stokes A, Bauer J H, Hudson N P. Transmission of yellow fever to Macacus rhesus: Preliminary note. JAMA. 1928; 90: 253–4
   Google Scholar
• Stokes A, Bauer J H, Hudson N P. Experimental transmission of yellow fever to laboratory animals. Am J Trop Med. 1928; 8: 103–64
   Google Scholar
• Monath T P, Heinz F X. Flaviviruses. Fields B N, Knipes D M, Howley P M. Fields Virology, 3rd ed, pp. 961–1034, Philadelphia, Lippincott-Raven Publishers. 1995
   Google Scholar
• Monath T P. Yellow Fever: An update. Lancet Infect Dis. 2001; 1: 11–20. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• World Health Organization. Prevention and control of yellow fever in Africa. Geneva, WHO. 1986
   Google Scholar
• Hahn C S, Dalrymple J M, Strauss J H, et al, Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proc Natl Acad Sci USA. 1987; 84: 2019–23. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Monath T P. Yellow fever. Plotkin S, Orenstein W A. Vaccines, 3rd ed., pp. 815–79, Philadelphia, W.B. Saunders. 1999
   Google Scholar
• De Beeck O A, Molenkamp R, Caron M, et al, Role of the transmembrane domains of prM and E proteins the formation of yellow fever virus envelope. J Virol. 2003; 77: 813–20
   Google Scholar
• Clarke D H. Antigenic analysis of certain group B arthropod-borne viruses by antibody absorption. J Exp Med. 1960; 111: 21–32. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fitzgeorge R, Bradish C J. The in vivo differentiation of strains of yellow fever virus in mice. J Gen Virol. 1980; 46: 1–14. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Chang G J, Cropp C B, Kinney R M, et al, Nucleotide sequence variation of the envelope protein gene identifies two distinct genotypes of yellow fever virus. J Virol. 1995; 69: 5773–80. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Deubel V, Digoutte J P, Monath T P, et al, Genetic heterogeneity of yellow fever virus strains from Africa and the Americas. J Gen Virol. 1986; 67: 209–13. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Monath T P. Yellow Fever: Victor, Victoria? Conqueror, Conquest? Epidemics and research in the last forty years and prospects for the future. Am J Trop Med Hyg. 1991; 45: 1–43. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Mutebi J P, Wang H, Li L, et al, Phylogenetic and evolutionary relationships among yellow fever isolates in Africa. J Virol. 2001; 75: 6999–7008. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Mutebi J P, Barrett A DT. The epidemiology of yellow fever in Africa. Microbes Infection. 2002; 4: 1459–68
   PubMed Web of Science ®Google Scholar
• Rice C M, Lenches E M, Eddy S R, et al, Nucleotide sequence of yellow fever virus: Implications for flavivirus gene expression and evolution. Science. 1985; 229: 726–33. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wang E, Weaver S C, Shope R E, et al, Genetic variation in yellow fever virus: duplication in 3′ noncoding region of strains from Africa. Virology. 1996; 225: 274–81. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lepineic L, Dalgarno L, Houng V TQ, et al, Geographical distribution and evolution of yellow fever viruses based on direct sequencing of genomic cDNA fragments. J Gen Virol. 1994; 75: 415–23
   Google Scholar
• Tomori O. Impact of yellow fever on the developing world. Adv Virus Res. 1999; 53: 5–34. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Monath T P. Yellow fever. Monath T P. The Arboviruses: Epidemiology and Ecology. pp. 139–231, Boca Raton, FL, CRC Press. 1989
   Google Scholar
• Vainio J, Cutts F. Yellow fever. WHO/EPI/GEN/98.11. Geneva, WHO. 1998
   Google Scholar
• Nasidi A, Monath T P, Vandenberg J, et al, Yellow fever vaccination and pregnancy: A four-year prospective study. Trans R Soc Trop Med Hyg. 1993; 87: 337–39. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• WHO, Yellow Fever Vaccine: WHO position paper. Wkly Epidemiol Rec. 2003; 78: 349–60
   Google Scholar
• Sérié C, Andral L, Lindrec A, et al, Etudes sur la fièvre jaune en Ethiopie. 6. Etude épidémiologique. Bull World Health Org. 1968; 38: 879–84
   Web of Science ®Google Scholar
• WHO. Yellow Fever reported cases. Annual epidemiological and vital statistics, Geneva 2003
   Google Scholar
• Beeuwkes H, Bauer J H, Mahaffy A F. Yellow fever endemicity in West Africa, with special reference to protection tests. Am J Trop Med. 1930; 10: 305–33
   Google Scholar
• Beeuwkes H, Mahaffy A F, Burke A W, et al, Yellow fever protection test surveys in French Cameroons, French Equatorial Africa, Belgian Congo, and Angola. Trans R Soc Trop Med Hyg. 1934; 28: 233–58
   Google Scholar
• Beeuwkes H, Mahaffy A F. The past incidence and distribution of yellow fever in West Africa as indicated by protection test surveys. Trans R Soc Trop Med Hyg. 1934; 28: 39–76
   Google Scholar
• Sawyer W A, Whitman L. Yellow fever immunity survey of North, East and South Africa. Trans R Soc Trop Med Hyg. 1936; 29: 297–412
   Google Scholar
• Findlay G M, Kirk R, MacCallum F O. Yellow fever and Anglo-Egyptian Sudan; distribution of immune bodies to yellow fever. Ann Trop Med. 1941; 35: 121–39
   Google Scholar
• Hughes T P, Jacobs H R, Burkes A W. Survey of yellow fever immunity in Uganda. Trans R Soc Trop Med Hyg. 1941; 35: 131–42
   Google Scholar
• Kirk R. An epidemic of yellow fever in the Nuba Mountains, Anglo-Egyptian Sudan. Ann Trop Med Parasitol. 1941; 35: 67–112
   Google Scholar
• Durieux C. Mass yellow fever vaccination in French Africa south of the Sahara. Smithburn K C, Durieux C, Koerber R. Yellow Fever Vaccination. pp. 115–21, Geneva, WHO. 1956
   Google Scholar
• Tapsoba L, Tomori O, Okwo Bele J-M, et al, Strategies for prevention and control of yellow fever. Gessner B A, Fletcher M, Parent du, Chelet I. Proceedings of the Fifth International Seminar on Immunization In Africa. Lyon, Foundation Marcel Merieux. pp. 98–9, 1996
   Google Scholar
• Tomori O, Tapsoba L, Ndikuyeze A, et al, Controlling yellow fever in Africa by the year 2010. Gessner B A, Fletcher M, Parent du Chelet I. Proceedings of the Fifth International Seminar on Immunization In Africa. Lyon, Foundation Marcel Merieux. pp. 183–86, 1996
   Google Scholar
• Robertson S E. Yellow Fever: The immunological basis for immunization. Geneva, WHO. 1993
   Google Scholar
• Sanders E J, Marfin A A, Tukei P M, et al, First recorded outbreak of yellow fever in Kenya, 1992–1993. I. Epidemiologic investigations. Am J Trop Med Hyg. 1998; 56: 644–48
   Google Scholar
• Reiter P, Cordellier R, Ouma J O, et al, First recorded outbreak of yellow fever in Kenya, 1992–1993. II Entomologic investigations. Am J Trop Med Hyg. 1998; 56: 649–56
   Google Scholar
• Vasconcelos P F, Rosa A P, Rodrigues S G, et al, Yellow fever in Para State, Amazon region of Brazil, 1998–1999: Entomologic and epidemiologic findings. Emerg Infect Dis. 2001; 7: 565–9. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Vasconcelos P F. Yellow Fever. Rev Soc Bras Med Trop. 2003; 36: 275–293. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Bryant J, Wang H, Cabezas C, et al, Enzootic transmission of yellow fever virus in Peru. Emerg Infect Dis. 2003; 9: 926–33. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Van der Stuyft P, Gianella A, Pirard M, et al, Urbanisation of yellow fever in Santa Crux, Bolivia. Lancet. 1999; 353: 1558–62. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Heraud J M, Hommel D, Hulin A, et al, First case of yellow fever in French Guiana since 1902. Emerg Infect Dis. 1999; 3: 429–32
   Google Scholar
• Rodhain F, Hannoun C, Jousset F X, et al, Isolation of yellow fever virus from 2 imported human cases. Bull Soc Pathol Exot Filiales. 1979; 72: 411–5. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nolla-Salas J, Saballs-Radresa J, Bada J L. Imported yellow fever in vaccinated tourist. Lancet. 1989; ii: 1275
   Google Scholar
• McFarland J M, Baddour L M, Nelson J E, et al, Imported Yellow fever in a United States citizen. Clin Infec Dis. 1997; 25: 1143–47
   PubMed Web of Science ®Google Scholar
• WHO, Yellow Fever 1996–1997 Part 1. Wkly Epidemiol Rec. 1998; 73: 354–9
   Google Scholar
• CDC, Fatal yellow fever in a traveller returning from Venezuela, 1999. MMWR Recomm Ref. 2000; 49: 303–5
   Google Scholar
• Teichmann D, Grobusch M P, Wesselmann H, et al, A hemorrhagic fever from the Cote d'Ivoire. Lancet. 1999; 354: 1608, [PUBMED], [INFOTRIEVE]
   Google Scholar
• WHO, Communicable Disease Surveillance and Response—Imported yellow fever case in the Netherlands February. 2000
   Google Scholar
• Colebunders R, Mariage J L, Coche J C, et al, A Belgian traveller who acquired yellow fever in the Gambia. Clin Infect Dis. 2002; 35: e113–6. [PUBMED], [INFOTRIEVE]
   Google Scholar
• CDC, Fatal yellow fever in a traveler returning from Amazonas Brazil. MMWR Recomm Ref. 2002; 51: 324–5
   Google Scholar
• Duddley S F. Can yellow fever spread into Asia? An essay on the ecology of mosquito-borne disease. J Trop Med Hyg. 1934; 37: 273–8
   Google Scholar
• Mahaffy A F, Hughes T P, Smithburn K C, et al, Isolation of yellow fever virus in Anglo-Egyptian Sudan. Ann Trop Med Parasitol. 1941; 35: 141–8
   Google Scholar
• Miller B R, Monath T P, Tabachnick W J, et al, Epidemic yellow fever caused by an incompetent mosquito vector. Trop Med Parasitol. 1989; 40: 396–9. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Monath T P, Giesberg J, Fierros E G. Does restricted distribution limit access and coverage of yellow fever vaccine in the United States?. Emerg Infect Dis. 1999; 4: 698–702
   Google Scholar
• Digoutte J-P, Cornet M, Deubel V, et al, Yellow fever. Porterfield J S. Exotic viral infections. Kass handbook of infectious diseases. pp. 67–102, London, Chapman & Hall Medical. 1995
   Google Scholar
• Kerr J A. The clinical aspects and diagnosis of yellow fever. Strode G K. Yellow fever. pp. 629–40, New York, McGraw-Hill. 1951
   Google Scholar
• Oudart J-L, Rey M. Proteinurie, proteinemie et transaminasemies dans 23 cas de fievre jaune confirmee. Bull World Health Organ. 1970; 42: 95–101. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Santos F, Pereira L C, Paiva P, et al, Coagulacao intravascular disseminada aguda na febre amarela: Dosagem dos factores da coagulacao. Brasilia Med. 1973; 9: 9–15
   Google Scholar
• Stevanson L D. Pathological changes in the central nervous system in yellow fever. Arch Pathol. 1939; 27: 249–54
   Google Scholar
• Jones M M, Wilson D C. Clinical features of yellow fever cases at Vom Christian Hospital during the 1969 epidemic on the Jos Plateau, Nigeria. Bull World Health Organ. 1972; 46: 63–5
   Google Scholar
• Tesh R B, Guzman H, Travassos da Rosa A PA, et al, Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus). 1. Virologic, biochemical and immunologic studies. J Infect Dis. 2001; 183: 1431–6. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Theiler M. The virus. Strode G K. Yellow fever. pp. 46–36, New York, McGraw Hill. 1951
   Google Scholar
• Tigertt W D, Berge T O, Gochenour W S, et al, Experimental yellow fever. Trans N Y Acad Sci. 1960; 22: 323–33
   Google Scholar
• Monath T P, Brinker K R, Chandler F W, et al, Pathophysiologic correlations in a rhesus monkey model of yellow fever. Am J Trop Med Hyg. 1981; 30: 431–41. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Monath T P, Ballinger M, Miller B M, et al, Detection of yellow fever viral RNA by nucleic acid hybridization and viral antigen by immunocytochemistry in fixed human liver tissues. Am J Trop Med Hyg. 1989; 40: 663–8. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Marianneau P, Steffan A M, Royer C, et al, Differing infection patterns of dengue and yellow fever viruses in a human hepatoma cell line. J Infect Dis. 1998; 178: 1270–8. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Co M D, Terajima M, Cruz J, et al, Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: Identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology. 2002; 293: 151–63. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Deubel V, Huerre M, Cathomas G, et al, Molecular detection and characterization of yellow fever virus in blood and liver specimens of a non-vaccinated fatal human case. J Med Virol. 1997; 53: 212–17. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Saluzzo J-P, Monath T P, Cornet M, et al, Comparison de different techniques virologiques pour la detection du virus de fievre jaune dans les prevements humains et des lots de moustiques. Interet d'une methode rapide de diagnostic par ELISA. Ann Virol (Inst Past). 1985; 136E: 115–29
   Google Scholar
• Koraka P, Zeller H, Niedrig M, et al, Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect. 2002; 4: 1209–15. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Monath T P. Yellow fever: A medically neglected disease. Report on a seminar. Rev Infect Dis. 1987; 9: 165–75. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Durieux C.. Preparation of yellow fever vaccine at the Institut Pasteur, Dakar. Smithburn K C, Durieux C, Koerber R. Yellow Fever Vaccination. Pp 31–2, Geneva, WHO. 1956
   Google Scholar
• Barrett A DT. Yellow fever vaccines. Biologicals. 1997; 25: 17–25. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Monath T P, Nasidi A. Should yellow fever vaccine be included in the Expanded Program of Immunization in Africa? A cost-effectiveness analysis for Nigeria. Am J Trop Med Hyg. 1993; 48: 274–99. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Marianneau P, Georges-Courbot M-C, Duebel V. Rarity of adverse effects after !7D yellow fever vaccination. Lancet. 2001; 358: 84–5. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tomori O. Factors in the reemergence of yellow fever in West Africa. Saluzzo J F, Dodet B. Factors in the Emergence of Arbovirus Diseases. pp.167–73, Paris, Foundation Marcel Merieux. 1997
   Google Scholar
• Nathan N, Barry M, Van Herp M, et al, Shortage of vaccines during a yellow fever outbreak in Guinea. Lancet. 2001; 358: 2129–30. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Osinusi K., Akinkugbe F M, Akinwolere O A, Fabiyi A. Safety and efficacy of yellow fever vaccine in children less than one-year old. West Afr J Med. 1990; 9: 200–3. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Hacker U T, Jelinek T, Erhardt S, et al, In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination. J Infect Dis. 1998; 177: 774–8. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Reinhardt B, Jaspert R, Niedrig M, et al, Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human flavivirus infection. J Med Virol. 1998; 56: 159–67. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Monath T P, Nichols R, Archambault W T, et al, Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX™ and YF-VAX®) in a Phase III multicenter, double-blind clinical trial. Am J Trop Med Hyg. 2002; 66: 533–41. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Freestone D S, Ferris R D, Weinberg A, et al, Stabilized 17D strain yellow fever vaccine: Dose response studies, clinical reactions and effects on hepatic function. J Biol Stand. 1977; 5: 181, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Jennings A D, Gibson C A, Miller B R, et al, Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J Infect Dis. 1994; 169: 512–8. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kelso J M, Mootrey G T, Tsai T F. Anaphylaxis from yellow fever vaccine. J Allergy Clin Immunol. 1999; 103: 698–701. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Martin M, Tsai T F, Cropp B, et al, Fever and multisystem organ failure associated with 17D- 204 yellow fever vaccination: A report of four cases. Lancet. 2001; 358: 98–104. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Werfel U, Popp W. Effects of yellow fever vaccination. Lancet. 2002; 358: 1909
   Google Scholar
• Vasconcelos P FC, Luna E J, Galler R, et al, Serious adverse events associated with yellow fever 17DD vaccine in Brazil: A report of two cases. Lancet. 2001; 358: 91–7. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chan R C, Penney D J, Little D, et al, Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet. 2001; 358: 121–2. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Galler R, Pugachev K V, Santos C L, et al, Phenotypic and molecular analyses of yellow fever 17DD vaccine viriuses associated with adverse events in Brazil. Virology. 2001; 290: 309–19. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nasidi A, Monath T P, DeCock K, et al, Urbana yellow fever epidemic in Western Nigeria 1987. Trans Roy Soc Trop Med Hyg. 1989; 83: 401–6. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Oyelami S A, Olaleye O D, Oyejide C O, et al, Severe post-vaccination reaction to 17D yellow fever vaccine in Nigeria. Rev Roum Virol. 1994; 45: 25–30. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Robert E, Vial T, Schaefer C, et al, Exposure to yellow fever vaccine in early pregnancy. Vaccine. 1999; 17: 283–5. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Receveur M C, Thiebaut R, Vedy S, et al, Yellow fever vaccination of human immuno deficiency Virus Infected Patients: Report of 2 cases. Clin Infect Dis. 2000; 31: e7–8. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sibailly T S, Wiktor S Z, Tsai T F, et al, Poor antibody response to yellow fever vaccination in children infected with human immunoi deficiency virus type 1. Pediatr Infect Dis J. 1997; 16: 1177–9. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kengsakul K, Sathirapongsasuti K, Punyagupta S. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai. 2002; 85: 131–4. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Guirakhoo F, Weltzin R, Chambers T J, et al, Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol. 2000; 74: 5477–85. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Monath T P, Levenbook I, Soike K, et al, Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: Dose-response effectiveness and extended safety testing in rhesus monkeys. J Virol. 2000; 74: 1742–51. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Monath T P, McCarthy K, Bedford P, et al, Clinical proof of principle for ChimeriVaxTM: Recombinant live, attenuated vaccines against flavivirus infections. Vaccine. 2002; 20: 1004–18. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• McAllister A, Arbetman A E, Mandl S, et al, Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases. J Virol. 2000; 74: 9197–205. [PUBMED], [INFOTRIEVE]
   Google Scholar
• WHO. WHO appeals for action to combat dramatic resurgence of yellow fever in Africa. Geneva, WHO, Press Release. 1996
   Google Scholar
• WHO Global Programme for Vaccines and /Division of Emerging and other Communicable diseases. A framework for control of yellow fever in Africa. Geneva, WHO. 1996
   Google Scholar